An overview of the basics of DM for the newly diagnosed and those who might appreciate a refresher on DM. This session reviews the genetics of the different types of DM as well as anticipation, the many body systems affected by this disease, what is common/not, anesthesia precautions, cognitive and neuropsychiatric effects, expectations, preparedness, and more. Dr. Greene is introduced by Southern California Support Group Facilitator, Loraine Dressler.

Presented during the New to the DM Community Track at the MDF 2020 Virtual Conference.

About the presenter:

Ericka Greene, MD, FAAN
Dr. Greene is Co-director, MDA Neuromuscular Clinics, Director, ALS Clinical Research Division, and head of the Neuromuscular Medicine Division in the Stanley H. Appel Department of Neurology at the Houston Methodist. Her clinical focus includes a wide range of neuromuscular disorders: Muscular Dystrophy, Myasthenia Gravis, Neuropathy, ALS, inflammatory myopathy, mitochondrial and metabolic myopathy. She directs clinical trial research in Neuromuscular Medicine and serves as primary investigator for several trials in ALS, Myasthenia Gravis, CIDP, and metabolic myopathies.

She is also education director of the Neurology residency program. She is Adjunct Professor, Director of Practice of Medicine for the ENMED program of the TAMHSC and Houston Methodist Hospital. She has served as a writer for the American Academy of Neurology’s Residency In-Service Training Examination Committee, and as an examiner for the American Board of Psychiatry and Neurology Part II Certification Board Exam. She has served as a member of the AAN Scientific Task Force Committee and serves as sub-committee Chair of the Neurology Self-Assessment Examination (Annual Meeting Edition 2012, 2013, 2014, 2015, 2016, & 2017) and program director for the Maintenance of Certification Program at the annual American Academy of Neurology (AAN) Breakthroughs in Neurology Regional Conferences (2015-2017) and ANN Annual program (2016-2017). She currently serves on the AAN Education Committee and as an AANEM Special Interest Group (SIG) Sessions Chair (2017-present).